Streetbeat News

Products Services

INCY

Incyte announced its dermatology portfolio data will be presented at the 2024 American Academy of Dermatology Annual Meeting, including two late-breaking abstracts on ruxolitinib cream (Opzelura) for hidradenitis suppurativa and povorcitinib (INCB54707) for prurigo nodularis. The event will highlight Incyte's commitment to addressing unmet needs in dermatology. Key data presentations are scheduled for March 11, 2024. Opzelura is FDA-approved for nonsegmental vitiligo and atopic dermatitis, while povorcitinib is in Phase 2 trials for several conditions.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:24 pm

LFVN

LifeVantage Corporation (NASDAQ:LFVN) announced the launch of its TrueScience Activated Skin Care Collection, a significant advancement in skincare technology. The collection, which builds on the successful launch of TrueRenew Daily Firming Complex, offers a regimen of multi-tasking products designed to activate skin health. The products, featuring a patented Nrf2 ingredient blend and other premium, planet-friendly ingredients, were first revealed in Canada and Europe on March 2 and will continue to launch globally. The skincare industry, valued at $146.7 billion in 2021, is expected to grow to $273.3 billion by 2031, with consumers seeking scientifically-backed, environmentally conscious products.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:23 pm

GSM

LONGi, a Chinese solar technology company, has signed a long-term silicon supply agreement with Ferroglobe PLC (NASDAQ:GSM), starting January 1, 2024. Ferroglobe will supply quartzite and metallurgical grade silicon to support LONGi's strategy of increasing purchases from Western suppliers. This partnership is aimed at enhancing LONGi's supply of high-efficiency and eco-friendly solar products globally. Ferroglobe recently reported a 36% decline in revenue for FY23 to $1.7 billion. Following the announcement, GSM shares saw a slight increase of 0.44% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

March 04, 2024 | 1:21 pm

ORA

Ormat Technologies, Inc. (NYSE:ORA) has signed a 30-year Power Purchase Agreement (PPA) with Electricité de France for a new 10MW geothermal power plant in Guadeloupe, adding to its existing 15MW Bouillante plant. The project, owning a 63.75% equity interest by Ormat, is expected to be operational by end of 2025, enhancing Ormat's total Caribbean geothermal capacity to 35MW. This development, featuring state-of-the-art sea water-cooled binary system technology, underscores Ormat's commitment to sustainable energy and its strategic relationship with EDF.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:21 pm

SOFI

Galileo Financial Technologies, independently operated by SoFi Technologies, Inc. (NASDAQ:SOFI), has expanded its collaboration with The Bancorp Bank to offer real-time payments via the RTP network from The Clearing House. This partnership aims to address cash flow challenges for SMBs and consumers by enabling instant money movement between bank accounts. The integration facilitates the implementation of instant payments for Galileo's clients, offering benefits such as faster transactions, enhanced customer satisfaction, and improved cash flow management. In Q3 2023, the RTP network recorded 64 million transactions worth $34 billion.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:20 pm

ARQT

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) announced its participation in the 2024 American Academy of Dermatology annual meeting with five presentations on topical roflumilast, including late-breaking clinical data from the INTEGUMENT-PED trial on children with atopic dermatitis and data from two pooled Phase 3 trials (DERMIS-1 and DERMIS-2) on plaque psoriasis. The presentations will cover new efficacy and patient-reported outcomes for roflumilast cream and foam in treating various dermatological conditions.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:18 pm

PRGO

Perrigo Company plc (NYSE:PRGO) has announced the commencement of shipments of Opill®, the first daily birth control pill available without a prescription in the U.S., to retailers nationwide. Opill® will be available for pre-order and in-store in the coming weeks. Approved by the FDA in July 2023, Opill® aims to improve accessibility and affordability of birth control, with prices ranging from $19.99 for a one-month supply to $89.99 for a six-month supply. Perrigo emphasizes the importance of this milestone in reproductive health and has also planned a cost-assistance program for low-income individuals.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:16 pm

NKGN

NKGen Biotech will present data on its Alzheimer's disease treatment, SNK01, at the Tau2024 Global Conference on March 25-26. This presentation could potentially impact the perception of NKGen Biotech's research progress and future prospects.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:16 pm

WULF

TeraWulf Inc. (NASDAQ:WULF) reported its February 2024 production and operations update, highlighting a 16% increase in bitcoin mining to 364 bitcoins with an average daily production rate of over 12.5 bitcoins. The company's operational hashrate increased by 39% month-over-month to 7.5 EH/s, with a self-mining capacity expected to surpass 8.0 EH/s in March. TeraWulf's power cost per bitcoin was $13,968, and it is on track to expand its capacity to 10 EH/s by mid-2024 with the completion of Building 4 at the Lake Mariner facility.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:15 pm

GRRR

Gorilla Technology Group Inc. (GRRR) and Lanner Electronics Inc. have announced a strategic partnership to develop AI-enabled cybersecurity products for the MENA region. This collaboration aims to enhance security solutions, offering seamless integration, enhanced performance, cost-effectiveness, and a comprehensive suite of cybersecurity features. Gorilla's involvement aligns with Egypt's Vision 2030 plan, emphasizing its commitment to economic growth and technological advancement in the region.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 1:12 pm